Daxocox

1 x 4 pc
Tablet
PA

Active substance

  • Enflicoxib : 100 mg
  • Species

    Dogs

    Indications

    For the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.

    Dose to be administered and administration route

    Oral use.

    Dosing interval is ONCE PER WEEK.


    First dose: 8 mg enflicoxib per kg body weight.

    Maintenance dose: repeat the treatment every 7 days at the dose of 4 mg enflicoxib per kg body weight.


    The veterinary medicinal product should be given immediately before or with the dog’s meal. The bodyweight of animals to be treated should be accurately determined to ensure administration of the correct dose.

    image

    Number of tablets to be administered

     

     

    FIRST DOSE

    8 mg/kg

    MAINTENANCE DOSE

    4 mg/kg

    Body weight (Kg) /Tablet size (mg)

    15

    mg

    30

    mg

    45

    mg 

    70

    mg

    100

    mg

    15

    mg

    30

    mg

    45

    mg 

    70

    mg

    100

    mg

    3 - 4.9 2         1        
    5 - 7.5   2         1      
    7.6 - 11.2     2         1    
    11.3 - 15   4         2      
    15.1 - 17.5       2         1  
    17.6 - 25         2         1
    25.1 - 35       4         2  
    35.1 - 50         4         2
    50.1 - 75         6         3

    Adverse reactions

    Vomiting, soft faeces and/or diarrhoea have been commonly reported in clinical trials, but most cases recovered without treatment.

    Apathy, loss of appetite or haemorrhagic diarrhoea have been reported in uncommon cases.

    Gastrointestinal ulceration has been reported in uncommon cases.


    Elevated blood urea and serum cholesterol levels were observed in healthy, young dogs at the recommended dose in a laboratory safety study.


    In case of adverse reactions the use of the veterinary medicinal product should be stopped and general supportive therapy, as for clinical overdose with NSAIDs, should be applied until complete resolution of the signs. Particular attention should be paid to maintain haemodynamic status.


    Gastrointestinal protectants and parenteral fluids, as appropriate, may be required for animals that experience gastrointestinal or renal adverse reactions.


    The frequency of adverse reactions is defined using the following convention:

    - very common (more than 1 in 10 animals treated displaying adverse reaction(s))

    - common (more than 1 but less than 10 animals in 100 animals treated)

    - uncommon (more than 1 but less than 10 animals in 1,000 animals treated)

    - rare (more than 1 but less than 10 animals in 10,000 animals treated)

    - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).

    References

    Leaflet is unavailable
    Dog
    PRICE Only for registered vets. Create a free profile to access all features.. Login
    Art. Nr. 32742/5005
    EAN 5055037402964
    PACKAGES
    Daxocox
    Animalcare Ltd
    1 x 4 pc
    32742/5005
    VETiSearch ApS - C.F. Richs Vej 99D - 2000 Copenhagen - Denmark - contact@vetisearch.co.uk - Legal registration number: 39926679
    VETiSearch.co.uk Copyright © 2025 . All rights reserved. This information is intended only for residents of Great Britain. The product information provided on this site is intended only for residents of Great Britain. Products may have different product information in different countries.